AI Solutions for Pathology in Pediatric Oncology
We are pleased to invite you to the upcoming GHN Artificial Intelligence Working Group Webinar, open to everyone, including SIOP Members and non‑members.
In this session, Dr. Alex Lobel will present the latest developments in AI solutions for pathology, including applications relevant to pediatric oncology. His talk will provide insights into emerging technological advancements, computational pathology methods, and opportunities for integrating AI into global childhood cancer diagnostics.
- Event date: March 26, 15:00 CET (Geneva)
- Registration link for SIOP Members: https://members.siop-online.org/event/AIWGMarch26 (SIOP Username and Password)
- Registration link for non-members: https://us06web.zoom.us/meeting/register/um8a7WShRK-EFSEapuZG9w
- This webinar is free and open to all
Speaker: Alexander Loebel, PhD
Dr. Alexander Loebel is a researcher and algorithm developer with more than twenty years of experience spanning academia and the high‑tech industry.
He earned his PhD in Bio‑Physics and Neurobiology in 2007 from the Weizmann Institute of Science (Rehovot, Israel).
From 2008 to 2016, Dr. Loebel served as a research fellow and later principal investigator at the Bernstein Center for Computational Neuroscience in Munich, Germany. During this time, he also taught at:
- The Graduate School for Systemic Neuroscience
- The Physics Faculty
- The Excellence Program at Ludwig‑Maximilian University (LMU) in Munich.
Between 2017 and 2023, he worked in the high‑tech sector, gaining broad expertise in data science and AI across multiple companies and startups. His work included:
- Developing AI‑driven computer vision algorithms
- Mentoring and advising a team of over 10 data scientists
- Supporting the growth of innovative AI‑focused organizations
Since February 2024, Dr. Loebel has led the Computational Pathology Research Laboratory at the Institute of Pathology, Sheba Medical Center, where he focuses on advancing AI‑enabled diagnostic tools and computational pathology research.
We warmly encourage clinicians, researchers, students, and all colleagues interested in AI and global pediatric oncology to join this insightful session.
